Optical apparatus for detecting and treating vulnerable plaque

• US 7,297,154 B2
• Filed: 11/12/2004
• Issued: 11/20/2007
• Est. Priority Date: 02/24/2003
• Status: Expired due to Fees

• Current Assignee: Hosheng Tu, Maxwell Sensors Inc.
• Original Assignee: Hosheng Tu, Maxwell Sensors Inc.
• Inventors: Ho, Winston Z., Tu, Hosheng
• Primary Examiner(s): Johnson, III; Henry M.
• Application Number:
  US10/988,416
• Publication Number:
  US 20050075704A1
• Time in Patent Office: 1,103 Days
• Field of Search: 128/898, 606 1- 19, 607 88- 94, 600/549
• US Class Current: 607/88
• CPC Class Codes: A61B 18/245 for removing obstructions in blood vessels or calculi
• CPC Class Codes: A61B 2018/2294 with a diffraction grating
• CPC Class Codes: A61B 2018/263 the conversion of laser energy into mechanical shockwaves taking place in a liquid
• CPC Class Codes: A61N 5/0601 Apparatus for use inside the body
• CPC Class Codes: A61N 5/062 Photodynamic therapy, i.e. excitation of an agent

Abstract

An optical apparatus and methods for monitoring temperature enabling detection and treatment of a vulnerable plaque of a patient comprising an elongate catheter, a plurality of outer optical fibers deployably disposed within the lumen of the catheter and suitably expandable in an outwardly radial manner configured for forming a basket shape, the outer fibers having at least one optical grating along an axis of the fiber wherein the at least one optical grating reflects a certain wavelength or intensity of the light beam, the certain wavelength or intensity of the reflected light beam being correlated to known temperature, and a longitudinal middle optical fiber emitting a light energy suitable for photodynamic therapy.

Claims

1. A method for photodynamically treating a tissue region of a patient, the method comprising:

a) providing an elongate tubular catheter at about said tissue region, wherein said catheter comprises at least one optic fiber having at least one optical grating along an axis of said fiber, wherein the fiber further comprises a light transmission zone intimately contacting said tissue region configured for photodynamic therapy, wherein said optical grating is coated with a material having a thermal coefficient that is greater than a thermal coefficient of the fiber;

b) administering a therapeutically effective amount of at least one photosensitizer composition, wherein the photosensitizer composition is at least partially localized to the tissue region;

c) light activating the localized photosensitizer composition to produce a phototoxic species, wherein the activating light is transmitted from the at least one optic fiber; and

d) treating the tissue region photodynamically.

2. The method of claim 1, wherein the at least one optical fiber further comprises an optical diffraction means for simultaneously measuring multiple peaks of said reflected light beam.

3. The method of claim 1, wherein said optical grating has a length between 0.2 and 40 mm.

4. The method of claim 1, wherein the step of providing the elongate tubular catheter is via a percutaneous procedure to the patient.

5. The method of claim 1, wherein the elongate tubular catheter comprises a plurality of optic fibers in a support scaffold structure that is radially expandable, and wherein at least one optic fiber comprises a light transmission zone intimately contacting said tissue region configured for photodynamic therapy.

6. The method of claim 1 further comprising a step of monitoring temperature of the tissue region, wherein a light source having a light beam is coupled into said at least one optical fiber;

said at least one optical grating reflecting a certain wavelength or intensity of said light beam, and said certain wavelength or intensity of the reflected light beam being correlated to the temperature.

7. The method of claim 6, wherein said monitored temperature is between 0.001 and 5.0°

C.

8. The method of claim 1, wherein the tissue region is vulnerable plaque of a blood vessel.

9. The method of claim 1, wherein the tissue region is a vessel wall of a blood vessel.

10. The method of claim 1, wherein the phototoxic species is reactive oxygen and/or chlorin.

11. The method of claim 1, wherein said optical grating is a Bragg grating.

12. The method of claim 1, wherein said optical grating is a long period grating.

13. The method of claim 1, wherein said optical grating is created by a UV or near UV light pattern.

14. The method of claim 1, wherein said catheter comprises a wire guide shaft located at a distal section of the catheter, said wire guide shaft being configured for riding said catheter on a guidewire.

15. The method of claim 1, wherein said photosensitizer composition is selected from the group consisting of porphyrins, chlorins, bacteriochlorins, purpurins, phthalocyanines, naphthalocyanines, texaphyrines, and combinations thereof.

16. The method of claim 1, wherein said photosensitizer composition is a non-tetrapyrrole photosensitizer.

17. The method of claim 1, wherein said photosensitizer composition is selected from the group consisting of photofrin, benzoporphyrin derivatives, tin ethyl etiopurpurin, sulfonated chloroaluminum phthalocyanines, methylene blue, motexafin lutetium, and combinations thereof.

18. The method of claim 1, wherein said at least one optical fiber has a core diameter and an external diameter with a surrounding cladding layer, wherein the core diameter is less than 10 μ

m.

19. The method of claim 1, wherein said at least one optical fiber has a core diameter and an external diameter with a surrounding cladding layer, wherein the external diameter is approximately between 0.1 mm and 2 mm.

20. The method of claim 1, wherein said at least one optical fiber has a core diameter and an external diameter with a surrounding cladding layer, wherein the core diameter is less than 100 μ

m.